Study details
Enrolling now
A Phase 0 Trial of PBA-0111
Pure Biologics S.A.
NCT IDNCT06700070ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
12
Study length
about 9 months
Ages
18+
Locations
1 site in LA
What this study is about
This trial is testing a new drug called PBA-0111 in people with certain types of cancer. The drug will be given directly into the tumor (intratumorally) at a very small dose using a special device. The goal is to see how the drug affects the area around the tumor.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take PBA-0111
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Number of Patients with Adverse Events
Body systems
Oncology